Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model

Shengzhi Liu, Yang Liu, Kazumasa Minami, Andy Chen, Qiaoqiao Wan, Yukun Yin, Liangying Gan, Aihua Xu, Nariaki Matsuura, Masahiko Koizumi, Yunlong Liu, Sungsoo Na, Jiliang Li, Harikrishna Nakshatri, Bai Yan Li, Hiroki Yokota

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

DNA damage response plays a critical role in tumor growth, but little is known about its potential role in bone metabolism. We employed selective inhibitors of Chk1 and examined their effects on the proliferation and migration of mammary tumor cells as well as the development of osteoblasts and osteoclasts. Further, using a mouse model of bone metastasis we evaluated the effects of Chk1 inhibitors on bone quality. Chk1 inhibitors blocked the proliferation, survival, and migration of tumor cells in vitro and suppressed the development of bone-resorbing osteoclasts by downregulating NFATc1. In the mouse model, Chk1 inhibitor reduced osteolytic lesions and prevented mechanical weakening of the femur and tibia. Analysis of RNAseq expression data indicated that the observed effects were mediated through the regulation of eukaryotic translation initiation factor 2 alpha, stress to the endoplasmic reticulum, S100 proteins, and bone remodeling-linked genes. Our findings suggest that targeting Chk1 signaling without adding DNA damaging agents may protect bone from degradation while suppressing tumor growth and migration.

Original languageEnglish (US)
Pages (from-to)9364-9378
Number of pages15
JournalOncotarget
Volume9
Issue number10
DOIs
StatePublished - Jan 1 2018

Fingerprint

Bone Resorption
Breast Neoplasms
Bone and Bones
Osteoclasts
Eukaryotic Initiation Factor-2
Eukaryotic Initiation Factors
Neoplasms
Endoplasmic Reticulum Stress
S100 Proteins
Bone Remodeling
Bone Development
Growth
Osteoblasts
Tibia
Femur
DNA Damage
Cell Movement
Down-Regulation
Neoplasm Metastasis
Checkpoint Kinase 1

Keywords

  • Bone resorption
  • Breast cancer
  • Checkpoint kinase
  • EIF2α

ASJC Scopus subject areas

  • Oncology

Cite this

Liu, S., Liu, Y., Minami, K., Chen, A., Wan, Q., Yin, Y., ... Yokota, H. (2018). Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model. Oncotarget, 9(10), 9364-9378. https://doi.org/10.18632/oncotarget.24286

Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model. / Liu, Shengzhi; Liu, Yang; Minami, Kazumasa; Chen, Andy; Wan, Qiaoqiao; Yin, Yukun; Gan, Liangying; Xu, Aihua; Matsuura, Nariaki; Koizumi, Masahiko; Liu, Yunlong; Na, Sungsoo; Li, Jiliang; Nakshatri, Harikrishna; Li, Bai Yan; Yokota, Hiroki.

In: Oncotarget, Vol. 9, No. 10, 01.01.2018, p. 9364-9378.

Research output: Contribution to journalArticle

Liu, S, Liu, Y, Minami, K, Chen, A, Wan, Q, Yin, Y, Gan, L, Xu, A, Matsuura, N, Koizumi, M, Liu, Y, Na, S, Li, J, Nakshatri, H, Li, BY & Yokota, H 2018, 'Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model', Oncotarget, vol. 9, no. 10, pp. 9364-9378. https://doi.org/10.18632/oncotarget.24286
Liu, Shengzhi ; Liu, Yang ; Minami, Kazumasa ; Chen, Andy ; Wan, Qiaoqiao ; Yin, Yukun ; Gan, Liangying ; Xu, Aihua ; Matsuura, Nariaki ; Koizumi, Masahiko ; Liu, Yunlong ; Na, Sungsoo ; Li, Jiliang ; Nakshatri, Harikrishna ; Li, Bai Yan ; Yokota, Hiroki. / Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model. In: Oncotarget. 2018 ; Vol. 9, No. 10. pp. 9364-9378.
@article{9f471b40eeab4c9c85ac23ed8963efa7,
title = "Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model",
abstract = "DNA damage response plays a critical role in tumor growth, but little is known about its potential role in bone metabolism. We employed selective inhibitors of Chk1 and examined their effects on the proliferation and migration of mammary tumor cells as well as the development of osteoblasts and osteoclasts. Further, using a mouse model of bone metastasis we evaluated the effects of Chk1 inhibitors on bone quality. Chk1 inhibitors blocked the proliferation, survival, and migration of tumor cells in vitro and suppressed the development of bone-resorbing osteoclasts by downregulating NFATc1. In the mouse model, Chk1 inhibitor reduced osteolytic lesions and prevented mechanical weakening of the femur and tibia. Analysis of RNAseq expression data indicated that the observed effects were mediated through the regulation of eukaryotic translation initiation factor 2 alpha, stress to the endoplasmic reticulum, S100 proteins, and bone remodeling-linked genes. Our findings suggest that targeting Chk1 signaling without adding DNA damaging agents may protect bone from degradation while suppressing tumor growth and migration.",
keywords = "Bone resorption, Breast cancer, Checkpoint kinase, EIF2α",
author = "Shengzhi Liu and Yang Liu and Kazumasa Minami and Andy Chen and Qiaoqiao Wan and Yukun Yin and Liangying Gan and Aihua Xu and Nariaki Matsuura and Masahiko Koizumi and Yunlong Liu and Sungsoo Na and Jiliang Li and Harikrishna Nakshatri and Li, {Bai Yan} and Hiroki Yokota",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.24286",
language = "English (US)",
volume = "9",
pages = "9364--9378",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "10",

}

TY - JOUR

T1 - Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model

AU - Liu, Shengzhi

AU - Liu, Yang

AU - Minami, Kazumasa

AU - Chen, Andy

AU - Wan, Qiaoqiao

AU - Yin, Yukun

AU - Gan, Liangying

AU - Xu, Aihua

AU - Matsuura, Nariaki

AU - Koizumi, Masahiko

AU - Liu, Yunlong

AU - Na, Sungsoo

AU - Li, Jiliang

AU - Nakshatri, Harikrishna

AU - Li, Bai Yan

AU - Yokota, Hiroki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - DNA damage response plays a critical role in tumor growth, but little is known about its potential role in bone metabolism. We employed selective inhibitors of Chk1 and examined their effects on the proliferation and migration of mammary tumor cells as well as the development of osteoblasts and osteoclasts. Further, using a mouse model of bone metastasis we evaluated the effects of Chk1 inhibitors on bone quality. Chk1 inhibitors blocked the proliferation, survival, and migration of tumor cells in vitro and suppressed the development of bone-resorbing osteoclasts by downregulating NFATc1. In the mouse model, Chk1 inhibitor reduced osteolytic lesions and prevented mechanical weakening of the femur and tibia. Analysis of RNAseq expression data indicated that the observed effects were mediated through the regulation of eukaryotic translation initiation factor 2 alpha, stress to the endoplasmic reticulum, S100 proteins, and bone remodeling-linked genes. Our findings suggest that targeting Chk1 signaling without adding DNA damaging agents may protect bone from degradation while suppressing tumor growth and migration.

AB - DNA damage response plays a critical role in tumor growth, but little is known about its potential role in bone metabolism. We employed selective inhibitors of Chk1 and examined their effects on the proliferation and migration of mammary tumor cells as well as the development of osteoblasts and osteoclasts. Further, using a mouse model of bone metastasis we evaluated the effects of Chk1 inhibitors on bone quality. Chk1 inhibitors blocked the proliferation, survival, and migration of tumor cells in vitro and suppressed the development of bone-resorbing osteoclasts by downregulating NFATc1. In the mouse model, Chk1 inhibitor reduced osteolytic lesions and prevented mechanical weakening of the femur and tibia. Analysis of RNAseq expression data indicated that the observed effects were mediated through the regulation of eukaryotic translation initiation factor 2 alpha, stress to the endoplasmic reticulum, S100 proteins, and bone remodeling-linked genes. Our findings suggest that targeting Chk1 signaling without adding DNA damaging agents may protect bone from degradation while suppressing tumor growth and migration.

KW - Bone resorption

KW - Breast cancer

KW - Checkpoint kinase

KW - EIF2α

UR - http://www.scopus.com/inward/record.url?scp=85041397424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041397424&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.24286

DO - 10.18632/oncotarget.24286

M3 - Article

AN - SCOPUS:85041397424

VL - 9

SP - 9364

EP - 9378

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 10

ER -